title: CC chemokine receptor 5 gene polymorphisms in beryllium disease.
abstract: CC chemokine receptor 5 (CCR5) is expressed on type-1 T-helper cells, which are involved in the pathogenesis of the granulomatous lung disease chronic beryllium disease (CBD). CCR5 gene (CCR5) polymorphisms are associated with sarcoidosis severity. The present study explores associations between CCR5 polymorphisms and CBD and its disease progression. Eight CCR5 polymorphisms were genotyped in CBD (n = 88), beryllium sensitisation (BeS; n = 86) and beryllium-exposed nondiseased controls (n = 173) using PCR with sequence-specific primers. Pulmonary function and bronchoalveolar lavage data were examined for associations with genotypes. There were no significant differences in genotype and allele frequency between CBD, BeS individuals and controls. In CBD, associations were found with decline in forced expiratory volume in 1 s and forced vital capacity and the CCR5 -3458 thymidine (T)T genotype (p<0.0001), and an increase in alveolar-arterial oxygen tension difference at rest (p = 0.003) and at maximum exercise (p = 0.01) and the -5663 adenine allele. Increased bronchoalveolar lavage lymphocyte numbers were associated with CCR5 -2459 guanine/-2135T (p = 0.01) only in the combined CBD and BeS group. This is the first study showing that CCR5 polymorphisms are associated with worsening pulmonary function over time in CBD, suggesting that CCR5 is important in the progression of pulmonary function in CBD. Further studies would be useful to clarify the mechanism whereby CCR5 polymorphisms affect progression of CBD.
authors.affiliation: Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Dept of Medicine, National Jewish Medical Health, 1400 Jackson Street, Denver, CO 80206, USA.
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: L
authors.initials: L
authors.lastname: Silveira
authors.forename: P
authors.initials: P
authors.lastname: Spagnolo
authors.forename: M
authors.initials: M
authors.lastname: Gillespie
authors.forename: E B
authors.initials: EB
authors.lastname: Gottschall
authors.forename: K I
authors.initials: KI
authors.lastname: Welsh
authors.forename: R M
authors.initials: RM
authors.lastname: du Bois
authors.forename: L S
authors.initials: LS
authors.lastname: Newman
authors.forename: L A
authors.initials: LA
authors.lastname: Maier
mesh_terms: D000368:Aged; D001607:Berylliosis / Q000235:genetics* / Q000378:metabolism; D016022:Case-Control Studies; D018450:Disease Progression; D005260:Female; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008137:Longitudinal Studies; D008168:Lung / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D019713:Receptors, CCR5 / Q000235:genetics*; D012507:Sarcoidosis / Q000235:genetics / Q000378:metabolism
chemical_list: D019713:Receptors, CCR5